CXS
Click for more information
0.00% 70.0¢ chemgenex pharmaceuticals ltd

Ann: Change of Director's Interest Notice , page-2

  1. kbear1
    15,518 Posts.
    lightbulb Created with Sketch. 43
    clock Created with Sketch.
    01/04/11
    15:24
    Post #: 8199770
    Amazing how the directors are able to sell their shares (presumably off market to Cephalon) whilst we benighted retail shareholders have to wait with baited breath to see what will unfold with the takeover or accept what the market will pay.

    What a complete shower!
    CXS Price at posting: 63.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.